NOVAVAX INC - NOTE 3.750% 2/0 Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2017 to Q1 2023

Type / Class
Debt / NOTE 3.750% 2/0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of NOVAVAX INC - NOTE 3.750% 2/0 across Reporting Periods

Period Principal Value Change Price (% of par) (Median) Investors
2023 Q1 $0 $0 -$320,115,312 0
2022 Q4 $320,793,000 $320,115,312 -$5,314,032 99.5% 25
2022 Q3 $317,882,137 $312,049,040 -$4,749,065 98.06% 22
2022 Q2 $321,740,000 $322,677,000 -$11,586,725 100.0% 21
2022 Q1 $331,115,000 $353,701,452 -$8,147,757 107.21% 20
2021 Q4 $331,205,000 $453,584,559 -$44,620,608 136.95% 26
2021 Q3 $363,771,000 $632,669,875 +$5,047,837 173.0% 29
2021 Q2 $356,835,000 $637,149,875 +$37,667,653 178.8% 25
2021 Q1 $331,058,000 $548,276,360 +$40,019,901 165.61% 23
2020 Q4 $335,633,000 $421,453,059 +$1,958,066 125.36% 24
2020 Q3 $332,045,000 $397,351,117 +$24,391,221 119.65% 29
2020 Q2 $319,093,000 $304,764,000 +$41,944,671 95.67% 15
2020 Q1 $275,414,000 $215,598,000 +$13,172,590 78.6% 12
2019 Q4 $274,948,000 $109,765,000 -$56,432 39.65% 16
2019 Q3 $274,898,000 $115,391,000 -$5,550,192 41.75% 17
2019 Q2 $288,318,000 $115,081,000 -$2,062,252 39.38% 17
2019 Q1 $294,444,382 $107,322,508 -$13,954,689 36.5% 21
2018 Q4 $308,563,000 $187,221,000 +$1,249,785 61.03% 27
2018 Q3 $309,463,000 $189,333,000 -$4,210,685 61.36% 32
2018 Q2 $318,105,000 $186,280,000 -$3,991,490 58.75% 25
2018 Q1 $325,540,000 $229,197,000 +$2,964,515 70.61% 25
2017 Q4 $322,058,000 $150,824,000 +$3,357,433 47.26% 22
2017 Q3 $315,058,000 $143,428,000 +$891,808 45.54% 21
2017 Q2 $314,008,000 $135,817,000 -$933,943 42.95% 20
2017 Q1 $315,714,000 $144,157,000 +$144,157,000 45.86% 20